Validation for human early embryonic substitutions (2017-05-11)
PCR and MiSeq validation for early embryonic substitution candidates from 400 Breast cancer patients This dataset contains all the data available for this study on 2017-05-11.
- 15/05/2017
- 4 samples
- DAC: EGAC00001000000
- Technology: Illumina MiSeq
- PUB DUO:0000019 (version: 2021-02-23)publication requiredThis data use modifier indicates that requestor agrees to make results of studies using the data available to the larger scientific community.
- US DUO:0000026 (version: 2021-02-23)user specific restrictionThis data use modifier indicates that use is limited to use by approved users.
- IS DUO:0000028 (version: 2021-02-23)institution specific restrictionThis data use modifier indicates that use is limited to use within an approved institution.
- GRU DUO:0000042 (version: 2021-02-23)general research useThis data use permission indicates that use is allowed for general research use for any research purpose.
Wellcome Trust Sanger Institute Cancer Genome Group Data Sharing Policy
Studies are experimental investigations of a particular phenomenon, e.g., case-control studies on a particular trait or cancer research projects reporting matching cancer normal genomes from patients.
| Study ID | Study Title | Study Type |
|---|---|---|
| EGAS00001001218 | Cancer Genomics |
This table displays only public information pertaining to the files in the dataset. If you wish to access this dataset, please submit a request. If you already have access to these data files, please consult the download documentation.
| ID | File Type | Size | Located in | |
|---|---|---|---|---|
| EGAF00000885113 | cram | 2.1 GB | ||
| EGAF00000885114 | cram | 2.8 GB | ||
| EGAF00000885115 | cram | 1.9 GB | ||
| EGAF00000885116 | cram | 2.9 GB | ||
| EGAF00001332987 | cram | 898.6 MB | ||
| EGAF00001343770 | cram | 814.6 MB | ||
| 6 Files (11.5 GB) | ||||